32Ge Biological Activity of Organogermanium Compounds

Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine

Volumn , Issue , 2005, Pages 279-295

  Lukevics, Edmunds ^a   Ignatovich, Luba ^b  

^a Latvian Academy of Sciences   (Latvia)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Dietary germanium supplements; Germanium and photosynthesis process; Germanium 132; Germatrane substituted derivatives; Kusanagi hypercholesterolemic (KHC); Maillard reaction; Organogermanium sesquioxides; Spirogermanium and germanium sesquioxanes

Indexed keywords

EID: 84889430280     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470864052.ch15     Document Type: Chapter

References (184)

1. C.A. Winkler, Ber. Dtsch. Chem. Ges., 19, 210-211 (1886).
2. C.A. Winkler, J. Prakt. Chem., 34, 177-229 (1886).
3. P.S. Gleim, in McGraw-Hill Encyclopedia of Science and Technology, vol. 8, 6th edn, McGraw-Hill, New York, 1987, pp. 76-83.
4. C.A. Winkler, J. Prakt. Chem., 36, 177-209 (1887).
5. C.A. Winkler, Ber. Dtsch. Chem. Ges., 20, 677-680 (1887).
6. T.O. Liewellyn, in Minerals Yearbook-1990, vol. 1 (Metals and Minerals), US Department of Interrior Bureau of Mines, US Government Printing Office, Washington, 1993, pp. 491-494.
7. K. Asai, Organic Germanium: A Medical Godsend, Ed. L. Kagakusha, Tokyo, 1977.
8. K. Asai, Miracle Cure: Organic Germanium, Japan Publ. Inc., Tokyo, 1980.
9. G.A. Schauss, Biol. Trace Elem. Res., 29, 267-280 (1991).
10. E. Lukevics, T.K. Gar, L.M. Ignatovich and V.F. Mironov, Biological Activity of Germanium Compounds, Zinatne, Riga, 1990 (in Russian).
11. E. Lukevics and L.M. Ignatovich, Appl. Organomet. Chem., 6, 113-126 (1992).
12. G. Atassi, Rev. Silicon, Germanium, Tin and Lead, 8, 219-235 (1985).
13. J.S. Thayer, Appl. Organomet. Chem., 1, 227-234 (1987).
14. R.R. Brutkiewicz and F. Suzuki, In Vivo, 1, 189-204 (1987).
15. S. Goodman, Med. Hypotheses, 26, 207-215 (1988).
16. E. Lukevics, S.Germane and L. Ignatovich, Appl.Organomet. Chem., 6, 543-564 (1992).
17. P. Köpf-Maier, Eur. J. Clin. Pharmacol., 47, 1-16 (1994).
18. E. Lukevics and L.M. Ignatovich, in The Chemistry of Organic Germanium, Tin and Lead Compounds, Ed. S. Patai, John Wiley & Sons Ltd, 1995, pp. 857-864.
19. S. Maeda, in The Chemistry of Organic Germanium, Tin and Lead Compounds, Ed. S. Patai, John Wiley & Sons Ltd, 1995, pp. 871-910.
20. G.B. Gerber and A. Leonard, Mutat. Res., 387, 141-146 (1997).
21. S.-H. Tao and P.M. Bolder, Regul. Toxicol. Pharmacol., 25, 211-219 (1997).
22. E. Lukevics and L. Ignatovich, in The Chemistry of Organic Germanium, Tin and Lead Compounds, Ed. Z. Rappoport, John Wiley & Sons Ltd, 2002, pp. 1653-1683.
23. M. Tsutsui, N. Kakimoto,D.D. Axtell et al., J. Am. Chem. Soc., 98, 8287-8289 (1976).
24. S. Nakayama, T. Tsuji and K. Usami, Showa Ikagakkai Zhasshi, 46, 227-235 (1986)
25. Chem. Abstr., 106, 334(1987).
26. F. Anger, J.P. Anger, L. Guillou et al., J. Toxicol. Clin. Exp., 11, 421-436 (1991).
27. F. Anger, J.P. Anger, L. Guillou and A. Papillon, Appl. Organomet. Chem., 6, 267-272 (1992).
28. T. Sanai, S. Okuda, K. Onoyama et al., Kidney International, 40, 882-890 (1991).
29. A. Hoshi, Drugs of the Future, 18, 905-908 (1993).
30. Y. Sugiya, S. Sakamaki and H. Satoh, Oyo Yakuri, 31, 1191-1200 (1986).
31. Chem. Abstr., 105, 164632(1986).
32. Y. Sugiya, K. Yoshida, K. Eda et al, Oyo Yakuri, 32, 139-152 (1986).
33. Chem. Abstr., 105, 164634(1986).
34. Y. Sugiya, K. Yoshida, K. Eda et al, Oyo Yakuri, 32, 123-138 (1986).
35. Chem. Abstr., 105, 164633(1986).
36. M. Kagoshima and M. Suzuki, J. Med. Pharm. Sci., 15, 1497-1502 (1986).
37. K. Asano, M. Yamano, K. Haruyama et al., J. Toxicol. Sci., 19(II), 131-143 (1994).
38. M. Nagata, T. Yoneyama, K. Yanagida et al., J. Toxicol. Sci., 10, 333-341 (1985).
39. S. Okada, S. Kijama, Y. Oh et al., Curr. Ther. Res., 141, 265-273 (1987).
40. A.G. Schauss, Ren. Fail., 13, 1-4 (1991).
41. J.I. Van der Spoel, B.H.C. Stricker, M.R. Esseveld and M.E.I. Schipper, Lancet, 336, 117(1990).
42. A. Takeuchi, N. Yoshizawa, S. Oshima et al., Nephron, 60, 436-442 (1992).
43. B. Hess, J. Raisin, A. Zimmermann et al., Am. J. Kidney Dis., 21, 548-552 (1993).
44. A. Shinohara, M. Chiba and Y. Inaba, J. Anal. Toxicol., 23, 625-631 (1999).
45. H. Brandenbergen and M. Roth, in Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists, Eds. H. Brandenbergen, R.A.A. Maes and W. de Gruyter, 1997, pp. 285-344.
46. S. Nakai, S. Chittrakarn and T. Togashi, Oyo Yakuri, 56, 1-16 (1998)
47. Chem. Abstr., 130, 20310(1999).
48. H. Fukazawa, Y. Ohashi, S. Sekiyama et al., Head Neck Surg., 16, 30-38 (1994).
49. H. Aso, F. Suzuki, T. Yamaguchi et al., Microbiol. Immunol., 29, 65-74 (1985).
50. S. Arai, Y. Tomita, T. Munakata et al., Int. J. Immunother., 3, 97-103 (1987).
51. T. Munakata, S. Arai, K. Kuwano et al., J. Interferon Res., 7, 69-76 (1987).
52. F. Suzuki, R.B. Brutkiewicz and R.B. Pollard, Int. J. Immunother., 2, 239-245 (1986).
53. K. Miyao and N. Tanaka, Drugs of the Future, 13, 441-453 (1988).
54. L. Pronai and S. Arimori, Biotherapy, 4, 1-8 (1992).
55. M. Kuwabara, J. Vet. Sci., 55, 471-473 (1993).
56. K. Ikemoto, M. Kobayashi, T. Fukumoto et al., Experientia, 52, 159-166 (1996).
57. S. Yokochi, Y. Ishiwata, H. Hashimoto et al., Scand. J. Immunol., 48, 183-191 (1998).
58. H. Kobayashi, H. Aso, N. Ishida et al., Immunopharm. Immunotoxicol., 14, 841-864 (1992).
59. H. Aso, F. Suzuki, T. Ebina and N. Ishida, J. Biol. Response Mod., 8, 180(1989).
60. T. Sato, A. Ishikawa and Y. Ishida, Pat. 834794 Belg. (1976), Chem. Abstr., 86, 37752y(1977).
61. N. Kumano, T. Ishikawa, S. Koinumaru et al., Tohoku J. Exp. Med., 146, 97-104 (1985).
62. N. Kumano, Y. Nakai, T. Ishikawa et al., Am. Soc. Microbiol., 1380-1382 (1981).
63. N. Kumano, Y. Nakai, T. Ishikawa et al., Am. Soc. Microbiol., 1525-1527 (1980).
64. E. Lukevics, S.K. Germane, A.A. Zidermane et al., Khim-Farm Zh., 18, 154-159 (1984).
65. Chem. Abstr., 101, 130791y(1984).
66. S. Arimori, K. Watanabe, M. Yoshida and T. Nagao, in Immunomodulation by microbial product and related synthetic compounds, Proc. Intern. symp., Amsterdam, 536-539 (1981).
67. M.G. Mainwaring, C. Poor, D.S. Zander and E. Harman, Chest, 117, 591-593 (2000).
68. H. Kobayashi, T. Komuro and H. Furue, Jap. J. Cancer Chemother., 13, 2588-2593 (1986).
69. A. Ishikawa, Y. Ishida, S. Ikegami et al., Pat. 54-21992 Jpn (1979)
70. Chem. Abstr., 92, 644n(1980).
71. N. Kakimoto, Pat. 54-147932 Jpn (1979), Chem. Abstr., 92,185931v(1980).
72. N. Kakimoto and K. Miyao, Pat. 54-160742 Jpn (1979), Chem. Abstr., 93, 80060c(1980).
73. H. Sato and A. Iwaguchi, Jap. J. Cancer Chemother., 6, 79-83 (1979).
74. F. Suzuki and R.B. Pollard, J. Interferon Res., 14, 223-233 (1994).
75. X. Ming, H. Yin and Z. Zhu, Chung Hua Wai Ko Tsa Chih, 34, 221-223 (1996), www.ncbi.nlm.nih.gov:80; PMID: 9387686.
76. Y. Liu, K. Ma, Y. Wang and Z. Chui, Zhongguo Mianyixue Zazhi, 11, 207-210 (1995).
77. Chem. Abstr., 124, 164456.
78. Y. Wang, Y. Liu and Z. Chui, Shengwu Huaxue Yu Shengwu Wuli Jinzhan, 24, 39-44 (1997)
79. Chem. Abstr., 128, 201(1998).
80. N. Kakimoto, M. Matsui, T. Takada and M. Akiba, Heterocycles, 23, 2681-2684 (1985).
81. H. Aso, E. Shibuya, F. Suzuki et al., Jap. J. Cancer Chemother., 12, 2345-2351 (1985).
82. T. Sato, Pat. 55-1677222 Jpn (1980), Chem. Abstr., 94, 185729b(1981).
83. S. Kato and M. Okamoto, Pat. 59-130814 Jpn (1984), Chem. Abstr., 101, 216415r(1984).
84. S. Kato and M. Okamoto, Pat. 60-01192 Jpn (1985), Chem. Abstr., 102, 204108a(1985).
85. Tokyo Soda Co., Ltd., Pat. 60-1191 Jpn (1985), Chem. Abstr., 102, 204107z(1985).
86. K. Takakusaki and H. Kakimoto, Pat. 59-31785 Jpn (1984), Chem. Abstr., 101, 91237a(1984).
87. K. Takakusaki and H. Kakimoto, Pat. 59-95283 Jpn (1984), Chem. Abstr., 101, 152092y(1984).
88. F. Jiang and C. Chen, Zhongguo Yaowu Huaxue Zazhi, 4, 1-3 (1994)
89. Chem. Abstr., 123, 9879j(1995).
90. F. Jiang, M. Liu and Z. Zlao, Zhongguo Yaowu Huaxue Zazhi, 5, 202-204 (1995)
91. Chem. Abstr., 124, 232624p().
92. Q. Wang, Z. Chen, Q. Zeng and R. Huang, Heteroatom Chem., 10, 209-212 (1999).
93. Q. Wang, Q. Zeng and Z. Chen, Heteroatom Chem., 10, 5-8 (1999).
94. M. Jiang, M. Fengchao, K. Lixia and M. Zeng, Zhongguo Yaowu Huaxue Zazhi, 7, 280-282 (1997)
95. Chem. Abstr., 130, 81583v(1999).
96. F. Jiang and M. Chen, Guangdong Weiliang Yuansu Kexue, 5, 41-44 (1998)
97. Chem. Abstr., 130, 47172(1999).
98. K. Kamura, N. Kakimoto and M. Akiba, Pat. 98-0003287 Jpn (1998), Chem. Abstr., 130, 163195(1999).
99. C. Han, L. Li, S. Cui et al., Weisheng Dulixue Zazhi, 12, 159-160 (1998).
100. Chem. Abstr., 130, 263260(1999).
101. M. Kumegawa and N. Kakimoto, Pat. 94-258811 Jpn (1994), Chem. Abstr., 125, 49328().
102. A. Fujii, N. Koboyama, J. Yamane et al., Gen. Pharmac., 24, 1527-1532 (1993).
103. H. Matsumoto, G.-Z. Jiang, T. Hashimoto et al., Int. J. Oral-Med. Sci., 1, 10-16 (2002).
104. Y. Wakabayashi, Biosci. Biotechnol. Biochem., 65, 1893-1896 (2001).
105. J. Chen, G. Zvang and S. Li, Yingyong Huaxue, 15, 55-58 (1998).
106. Chem. Abstr., 129, 225551(1998).
107. K. Nakamura, K. Nomoto, K. Kariya et al., Amino Acids, 1, 263-278 (1991).
108. N. Kakimoto, T. Yoshihara, H. Akao and M. Akiba, Pat. 94-657078 Jpn (1994), Chem. Abstr., 124, 176539().
109. N.J. Unakar, M. Johnson, J. Tsui et al., Exp. Eye Res., 61, 155-164 (1995).
110. N.J. Unakar, J. Tsui and M. Johnson, Curr. Eye Res., 16, 832-837 (1997).
111. L.M. Rice, J.W. Wheeler and C.F. Geschickter, J. Heterocycl. Chem., 11, 1041-1047 (1974).
112. M.C. Henry, E. Rosen, C.D. Port and B.S. Levine, Cancer Treat. Rep., 64, 1207-1210 (1980).
113. J.H. Saiers, B. Blumenstein, M. Slavik et al., Cancer Treat. Rep., 71, 1305-1306 (1987).
114. J. Harvey, M. McFadden, F.P. Smith et al., Invest. New Drugs, 8, 53-56 (1990).
115. M. Slavik, O. Blanc and J. Davis, Invest. New Drugs, 1, 255-234 (1983).
116. M. Slavik and J.H. Saiers, Cancer, 11, 25-30 (1981).
117. M. Slavik, L. Elias, J. Mrema and J.H. Saiers, Drugs Exp. Clin. Res., 8, 379-385 (1982).
118. J.J. Kavanagh, P.B. Saul, L.J. Copeland et al., Cancer Treat. Rep., 69, 139-140 (1985).
119. N. Vogelzang, D. Gesme and B. Kennedy, Am. J. Clin. Oncol., 8, 341-344 (1985).
120. F.H. Dexeus, C. Logothetis, M.L. Samuels and B. Hassan, Cancer Treat. Rep., 70, 1129-1130 (1986).
121. K.J. Padya, A. Kramar, R.F. Asbury and D.G. Haller, Am. J. Clin. Oncol., 11, 496-498 (1988).
122. C.K. Mirabelli, A.M. Badger, C.P. Sung et al., Anticancer Drug Des., 3, 231-242 (1989).
123. E.A. Monnot, C.G. Kindberg, T.S. Johnson et al., Int. J. Pharm., 60, 41-52 (1990).
124. B.F. Kimler, J. Neurooncol., 20, 103-109 (1994).
125. R.F. Asbry, A. Cnaan, L. Johnson et al., Am. J. Clin. Oncol., 17, 166-169 (1994).
126. B.T. Hill, S.A. Whatley, A.S. Bellamy et al., Cancer Res., 42, 2852-2856 (1982).
127. S.J. Yang and S. Rafla, Am. J. Clin. Oncol., 5, 331-337 (1983).
128. B.T. Hill and R.D. Whelan, Invest. New Drugs, 4, 359-365 (1986).
129. A.M. Badger, D.A. Schwartz, D.H. Picker et al., J. Med. Chem., 33, 2963-2970 (1990).
130. P.J. Byrne, P.S. Schein, P. Maguire et al., Proc. Am. Assoc. Cancer Res., Am. Soc. Clin. Oncol., 21, 351(1980).
131. P.S. Schein, M. Slavik, T. Smyth et al., Cancer Treat. Rep., 64, 1051-1056 (1980).
132. T.E. Lad, R.R. Blought, M. Evrard et al., Invest. New Drugs, 7, 223-224 (1989).
133. D.S. Ettinnger, D.M. Finkelstein, M.D. Abeloff et al., Invest. New Drugs, 8, 183-185 (1990).
134. D.S. Ettinnger, D.M. Finkelstein, R.C. Donehower et al., Med. Pediatr. Oncol., 17, 197-201 (1989).
135. Y. Novik, L.M. Ryan, D.G. Haller et al., Med. Oncol., 16, 261-266 (1999).
136. L.M. Weiss, M. Wittner, S. Wasserman et al., J. Infect. Dis., 168, 1289-1292 (1993).
137. E. Lukevics, L. Ignatovich and S. Belyakov, J. Organomet. Chem., 588, 222-230 (1999).
138. S.S. Karlov and G.S. Zaitseva, Chem. Heterocycl. Compd., 37, 1325-1357 (2001).
139. E. Lukevics, L.M. Ignatovich and S.K. Germane, Chem. Heterocycl. Compd., 31, 1241-1248 (1995).
140. E. Lukevics, S.K. Germane, M.A. Trushule et al, Khim.-Farm. Zh., 21, 1070-1074 (1987).
141. Chem. Abstr., 108, 68300b(1988).
142. E. Lukevics, L. Ignatovich, N. Porsiurova and S. Germane, Appl. Organomet. Chem., 2, 115-120 (1988).
143. E. Lukevics, S. Germane, M. Trushule et al., Latv. PSR Zinat. Akad. Vestis, N5, 79-82 (1988).
144. Chem. Abstr., 109, 104165t(1988).
145. E. Lukevics, L. Ignatovich, N. Shilina and S. Germane, Appl. Organomet. Chem., 6, 261-266 (1992).
146. E. Lukevics and L. Ignatovich, Main Group Met. Chem., 17, 133-144 (1994).
147. L. Ignatovich, S. Belyakov, J. Popelis and E. Lukevics, Chem. Heterocycl. Compd., 36, 603-606 (2000).
148. E. Lukevics, L. Ignatovich, T. Shul'ga and S. Belyakov, Main Group Met. Chem., 25, 463-464 (2002).
149. E. Lukevics, L. Ignatovich, T. Shul'ga et al., J. Organomet. Chem., 659, 165-171 (2002).
150. K. Sato and H. Kakimoto, Pat. 59-31784 Jpn(1984).
151. Chem. Abstr., 101, 91238b(1984).
152. T.K. Miyamoto, N. Sugita, Y. Matsumoto et al., Chem. Lett. 1695-1698 (1983).
153. P. Köpf-Maier, Cancer Chemother. Pharmacol., 23, 225-230 (1989).
154. P. Köpf-Maier, C. Janik and H. Schumann, Inorg. Chim. Acta, 152, 75-76 (1988).
155. K. Sato and H. Kakimoto, Pat. 59-193897 Jpn (1984), Chem. Abstr., 103, 22788k(1985).
156. E. Lukevics, L. Ignatovich and I. Shestakova, Appl. Organomet. Chem., 17, 898-905 (2003).
157. L. Ignatovich, Dz. Zarina, I. Shestakova et al., Metal-Based Drugs, 8, 211-214 (2002).
158. F. Li, Z. Zhang and H. Gao, Metal-Based Drugs, 3, 241-242 (1996).
159. E.Ya. Lukevics, L.M. Ignatovich, A.A. Zidermane and A.Zh. Dauvarte, Latv.PSR. Zinat. Akad. Vestis, ser. chim., 483-486 (1984)
160. Chem. Abstr., 101, 211331a(1984).
161. E. Lukevics, P. Arsenyan, S. Germane and I. Shestakova, Appl. Organomet. Chem., 13, 795-798 (1999).
162. E. Lukevics, P. Arsenyan, I. Shestakova et al., Metal-Based Drugs, 7, 63-66 (2000).
163. S. Xuequing, Y. Zhiqiang, X. Qinglan and L. Jinshan, J. Organomet. Chem., 566, 103-110 (1998).
164. M.A. Choudhary, M. Mazhar, S. Ali et al., Metal-Based Drugs, 8, 275-281 (2002).
165. S.Ya. Melnic, A.A. Bakhmedova, T.P. Nedorezova et al., Bioorg. Khim., 11, 1248-1252 (1985).
166. S.Ya. Melnic, A.A. Bakhmedova, T.D. Miniker et al., Bioorg. Khim., 10, 1645-1654 (1984).
167. S. Ninomiya, F. Liu, H. Nakagawa et al., Chem. Pharm. Bull., 34, 3273-3278 (1986).
168. T. Yamakawa, H. Kagechika, E. Kawachi et al., J. Med. Chem., 33, 1430-1437 (1990).
169. M. Merget, K. Gunter, M. Bernd et al., J. Organomet. Chem., 628, 183-194 (2001).
170. R. Tacke, M. Merget, R. Bertermann et al., Organometallics, 19, 3486-3497 (2000).
171. R. Tacke, T. Heinrich, T. Korner et al., Phosphorus Sulfur Silicon, 150/151, 69-87 (1999).
172. J. Satgé, A. Gazes, M. Bouchaut et al., Eur. J. Med. Chem.-Chem. Ther., 17, 433-436 (1982).
173. M. Fatome, H. Sentenac-Roumanou, C. Lion et al., Eur. J. Med. Chem., 19, 119-122 (1984).
174. M. Fatome, H. Sentenac-Roumanou, C. Lion et al., Eur. J. Med. Chem.-Chem. Ther., 23, 257-266 (1988).
175. J. Satgé, G. Rima, M. Fatome et al., Eur. J. Med. Chem., 24, 48-54 (1989).
176. G. Rima, J. Satgé, M. Fatome et al., Eur. J. Med. Chem., 26, 291-297 (1991).
177. G. Rima, J. Satgé, H. Sentenac-Roumanou et al., Appl. Organomet. Chem., 10, 113-123 (1996).
178. G. Rima, J. Satgé, H. Sentenac-Roumanou et al., Main Group Met. Chem., 20, 255-267 (1997).
179. G. Rima, J. Satgé, R. Dagiral et al., Metal-Based Drugs, 5, 139-146 (1998).
180. G. Rima, J. Satgé, R. Dagiral et al., Metal-Based Drugs, 6, 49-60 (1999).
181. B. Célaries, G. Rima, L. Court et al., Metal-Based Drugs, 8, 199-210 (2001).
182. B. Célaries, C. Amourette, C. Lion, G. Rima, Appl. Organomet. Chem., 17, 135-138 (2003).
183. R. Tacke, B. Becker, D. Berg et al., J. Organomet. Chem., 438, 45-55 (1992).
184. Monsanto Co., Pat. 538231 EP (1993), Chem. Abstr., 119, 160256S(1993).